{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:47:00Z","timestamp":1785548820758,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,9,20]],"date-time":"2008-09-20T00:00:00Z","timestamp":1221868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00134-008-1268-4","type":"journal-article","created":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T06:36:44Z","timestamp":1221806204000},"page":"2176-2184","source":"Crossref","is-referenced-by-count":63,"title":["Serum levels of osteopontin are increased in SIRS and sepsis"],"prefix":"10.1007","volume":"34","author":[{"given":"Rosanna","family":"Vaschetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Nicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Boggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Piccolella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Mesturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Damnotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Navalesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Della Corte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Dianzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Chiocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,20]]},"reference":[{"key":"1268_CR1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00134-001-1143-z","volume":"28","author":"C Alberti","year":"2002","unstructured":"Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulme R, Lepage E, Le GR (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108\u2013121","journal-title":"Intensive Care Med"},{"key":"1268_CR2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2796.1998.00379.x","volume":"244","author":"L Leibovici","year":"1998","unstructured":"Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:379\u2013386","journal-title":"J Intern Med"},{"key":"1268_CR3","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00003246-199609000-00002","volume":"24","author":"J Cohen","year":"1996","unstructured":"Cohen J, Carlet J (1996) INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med 24:1431\u20131440","journal-title":"Crit Care Med"},{"key":"1268_CR4","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/jama.1994.03510470040032","volume":"271","author":"CJ Fisher Jr","year":"1994","unstructured":"Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL et al (1994) Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 271:1836\u20131843","journal-title":"JAMA"},{"key":"1268_CR5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.287.5454.860","volume":"287","author":"S Ashkar","year":"2000","unstructured":"Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H (2000) Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287:860\u2013864","journal-title":"Science"},{"key":"1268_CR6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200319190","volume":"112","author":"EM Gravallese","year":"2003","unstructured":"Gravallese EM (2003) Osteopontin: a bridge between bone and the immune system. J Clin Invest 112:147\u2013149","journal-title":"J Clin Invest"},{"key":"1268_CR7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jlb.60.3.397","volume":"60","author":"EE Rollo","year":"1996","unstructured":"Rollo EE, Laskin DL, Denhardt DT (1996) Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J Leukoc Biol 60:397\u2013404","journal-title":"J Leukoc Biol"},{"key":"1268_CR8","first-page":"173","volume":"182","author":"F Takahashi","year":"2004","unstructured":"Takahashi F, Takahashi K, Shimizu K, Cui R, Tada N, Takahashi H, Soma S, Yoshioka M, Fukuchi Y (2004) Osteopontin is strongly expressed by alveolar macrophages in the lungs of acute respiratory distress syndrome. Lung 182:173\u2013185","journal-title":"Lung"},{"key":"1268_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MCG.0b013e31802d6268","volume":"41","author":"R Mishima","year":"2007","unstructured":"Mishima R, Takeshima F, Sawai T, Ohba K, Ohnita K, Isomoto H, Omagari K, Mizuta Y, Ozono Y, Kohno S (2007) High plasma osteopontin levels in patients with inflammatory bowel disease. J Clin Gastroenterol 41:167\u2013172","journal-title":"J Clin Gastroenterol"},{"key":"1268_CR10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/keh558","volume":"44","author":"CK Wong","year":"2005","unstructured":"Wong CK, Lit LC, Tam LS, Li EK, Lam CW (2005) Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford) 44:602\u2013606","journal-title":"Rheumatology (Oxford)"},{"key":"1268_CR11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2005.02.020","volume":"163","author":"A Chiocchetti","year":"2005","unstructured":"Chiocchetti A, Comi C, Indelicato M, Castelli L, Mesturini R, Bensi T, Mazzarino MC, Giordano M, D\u2019Alfonso S, Momigliano-Richiardi P, Liguori M, Zorzon M, Amoroso A, Trojano M, Monaco F, Leone M, Magnani C, Dianzani U (2005) Osteopontin gene haplotypes correlate with multiple sclerosis development and progression. J Neuroimmunol 163:172\u2013178","journal-title":"J Neuroimmunol"},{"key":"1268_CR12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ana.10606","volume":"53","author":"MH Vogt","year":"2003","unstructured":"Vogt MH, Lopatinskaya L, Smits M, Polman CH, Nagelkerken L (2003) Elevated osteopontin levels in active relapsing-remitting multiple sclerosis. Ann Neurol 53:819\u2013822","journal-title":"Ann Neurol"},{"key":"1268_CR13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cyto.2005.01.014","volume":"30","author":"S Inomata","year":"2005","unstructured":"Inomata S, Shijubo N, Kon S, Maeda M, Yamada G, Sato N, Abe S, Uede T (2005) Circulating interleukin 18 and osteopontin are useful to evaluate disease activity in patients with tuberculosis. Cytokine 30:203\u2013211","journal-title":"Cytokine"},{"key":"1268_CR14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/00365520510024061","volume":"41","author":"M Arai","year":"2006","unstructured":"Arai M, Yokosuka O, Kanda T, Fukai K, Imazeki F, Muramatsu M, Seki N, Miyazaki M, Ochiai T, Hirasawa H, Saisho H (2006) Serum osteopontin levels in patients with acute liver dysfunction. Scand J Gastroenterol 41:102\u2013110","journal-title":"Scand J Gastroenterol"},{"key":"1268_CR15","doi-asserted-by":"crossref","unstructured":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864\u2013874","DOI":"10.1097\/00003246-199206000-00025"},{"key":"1268_CR16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818\u2013829","journal-title":"Crit Care Med"},{"key":"1268_CR17","first-page":"707","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, de MA, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707\u2013710","journal-title":"On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med"},{"key":"1268_CR18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/(SICI)1097-0258(19980515)17:9<1033::AID-SIM784>3.0.CO;2-Z","volume":"17","author":"CE Metz","year":"1998","unstructured":"Metz CE, Herman BA, Shen JH (1998) Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. Stat Med 17:1033\u20131053","journal-title":"Stat Med"},{"key":"1268_CR19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","volume":"164","author":"S Harbarth","year":"2001","unstructured":"Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J (2001) Diagnostic value of procalcitonin, interleukin 6, and interleukin 8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164:396\u2013402","journal-title":"Am J Respir Crit Care Med"},{"key":"1268_CR20","first-page":"488","volume":"23","author":"A Oberholzer","year":"2005","unstructured":"Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP, Moldawer LL (2005) Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23:488\u2013493","journal-title":"Shock"},{"key":"1268_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1517\/14728222.11.1.81","volume":"11","author":"S Jain","year":"2007","unstructured":"Jain S, Chakraborty G, Bulbule A, Kaur R, Kundu GC (2007) Osteopontin: an emerging therapeutic target for anticancer therapy. Expert Opin Ther Targets 11:81\u201390","journal-title":"Expert Opin Ther Targets"},{"key":"1268_CR22","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.4049\/jimmunol.168.5.2096","volume":"168","author":"M Jansson","year":"2002","unstructured":"Jansson M, Panoutsakopoulou V, Baker J, Klein L, Cantor H (2002) Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1\/osteopontin-deficient mice. J Immunol 168:2096\u20132099","journal-title":"J Immunol"},{"key":"1268_CR23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0167-5699(00)01715-1","volume":"21","author":"AW O\u2019Regan","year":"2000","unstructured":"O\u2019Regan AW, Nau GJ, Chupp GL, Berman JS (2000) Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol Today 21:475\u2013478","journal-title":"Immunol Today"},{"key":"1268_CR24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jneuroim.2004.09.004","volume":"158","author":"M Comabella","year":"2005","unstructured":"Comabella M, Pericot I, Goertsches R, Nos C, Castillo M, Blas NJ, Rio J, Montalban X (2005) Plasma osteopontin levels in multiple sclerosis. J Neuroimmunol 158:231\u2013239","journal-title":"J Neuroimmunol"},{"key":"1268_CR25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9440(10)64514-2","volume":"157","author":"GJ Nau","year":"2000","unstructured":"Nau GJ, Chupp GL, Emile JF, Jouanguy E, Berman JS, Casanova JL, Young RA (2000) Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection. Am J Pathol 157:37\u201342","journal-title":"Am J Pathol"},{"key":"1268_CR26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1507\/endocrj.51.499","volume":"51","author":"H Yamaguchi","year":"2004","unstructured":"Yamaguchi H, Igarashi M, Hirata A, Tsuchiya H, Sugiyama K, Morita Y, Jimbu Y, Ohnuma H, Daimon M, Tominaga M, Kato T (2004) Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients. Endocr J 51:499\u2013504","journal-title":"Endocr J"},{"key":"1268_CR27","doi-asserted-by":"crossref","unstructured":"Zhao L, Li T, Wang Y, Pan Y, Ning H, Hui X, Xie H, Wang J, Han Y, Liu Z, Fan D (2008) Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Int J Clin Pract 62(7):1056\u20131062","DOI":"10.1111\/j.1742-1241.2007.01368.x"},{"key":"1268_CR28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/art.20808","volume":"52","author":"S D\u2019Alfonso","year":"2005","unstructured":"D\u2019Alfonso S, Barizzone N, Giordano M, Chiocchetti A, Magnani C, Castelli L, Indelicato M, Giacopelli F, Marchini M, Scorza R, Danieli MG, Cappelli M, Migliaresi S, Bigliardo B, Sabbadini MG, Baldissera E, Galeazzi M, Sebastiani GD, Minisola G, Ravazzolo R, Dianzani U, Momigliano-Richiardi P (2005) Two single-nucleotide polymorphisms in the 5\u2032 and 3\u2032 ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum 52:539\u2013547","journal-title":"Arthritis Rheum"},{"key":"1268_CR29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1473-3099(07)70052-X","volume":"7","author":"BM Tang","year":"2007","unstructured":"Tang BM, Eslick GD, Craig JC, McLean AS (2007) Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7:210\u2013217","journal-title":"Lancet Infect Dis"},{"key":"1268_CR30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-8981(02)00101-8","volume":"323","author":"M Meisner","year":"2002","unstructured":"Meisner M (2002) Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 323:17\u201329","journal-title":"Clin Chim Acta"},{"key":"1268_CR31","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00134-002-1398-z","volume":"28","author":"EJ Giamarellos-Bourboulis","year":"2002","unstructured":"Giamarellos-Bourboulis EJ, Mega A, Grecka P, Scarpa N, Koratzanis G, Thomopoulos G, Giamarellou H (2002) Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 28:1351\u20131356","journal-title":"Intensive Care Med"},{"key":"1268_CR32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1034\/j.1399-6576.2002.460412.x","volume":"46","author":"E Ruokonen","year":"2002","unstructured":"Ruokonen E, Ilkka L, Niskanen M, Takala J (2002) Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 46:398\u2013404","journal-title":"Acta Anaesthesiol Scand"},{"key":"1268_CR33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/0310057X0203000605","volume":"30","author":"S Tugrul","year":"2002","unstructured":"Tugrul S, Esen F, Celebi S, Ozcan PE, Akinci O, Cakar N, Telci L (2002) Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response. Anaesth Intensive Care 30:747\u2013754","journal-title":"Anaesth Intensive Care"},{"key":"1268_CR34","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/00003246-200004000-00007","volume":"28","author":"GA Wanner","year":"2000","unstructured":"Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W (2000) Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 28:950\u2013957","journal-title":"Crit Care Med"},{"key":"1268_CR35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0022-3476(98)70448-2","volume":"132","author":"H Doellner","year":"1998","unstructured":"Doellner H, Arntzen KJ, Haereid PE, Aag S, Austgulen R (1998) Interleukin 6 concentrations in neonates evaluated for sepsis. J Pediatr 132:295\u2013299","journal-title":"J Pediatr"},{"key":"1268_CR36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1651-2227.2003.tb00534.x","volume":"92","author":"B Resch","year":"2003","unstructured":"Resch B, Gusenleitner W, Muller WD (2003) Procalcitonin and interleukin 6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr 92:243\u2013245","journal-title":"Acta Paediatr"},{"key":"1268_CR37","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/j.1460-2075.1990.tb08316.x","volume":"9","author":"S Akira","year":"1990","unstructured":"Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T (1990) A nuclear factor for IL6 expression (NF-IL6) is a member of a C\/EBP family. EMBO J 9:1897\u20131906","journal-title":"EMBO J"},{"key":"1268_CR38","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1164\/ajrccm.164.12.2104139","volume":"164","author":"AW O\u2019Regan","year":"2001","unstructured":"O\u2019Regan AW, Hayden JM, Body S, Liaw L, Mulligan N, Goetschkes M, Berman JS (2001) Abnormal pulmonary granuloma formation in osteopontin-deficient mice. Am J Respir Crit Care Med 164:2243\u20132247","journal-title":"Am J Respir Crit Care Med"},{"key":"1268_CR39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1523-1755.2003.00767.x","volume":"63","author":"VP Persy","year":"2003","unstructured":"Persy VP, Verhulst A, Ysebaert DK, De Greef KE, De Broe ME (2003) Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 63:543\u2013553","journal-title":"Kidney Int"},{"key":"1268_CR40","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1128\/IAI.67.8.4223-4230.1999","volume":"67","author":"GJ Nau","year":"1999","unstructured":"Nau GJ, Liaw L, Chupp GL, Berman JS, Hogan BL, Young RA (1999) Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect Immun 67:4223\u20134230","journal-title":"Infect Immun"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-008-1268-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-008-1268-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-008-1268-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T10:35:33Z","timestamp":1588934133000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-008-1268-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,20]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1268"],"URL":"https:\/\/doi.org\/10.1007\/s00134-008-1268-4","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,20]]}}}